Eden Biodesign - 2007 press releases

2007 press releases

Eden Biodesign restructures its executive management team
20 November 2007

Download

Immunobiology (ImmBio) extend its collaboration with Eden Biodesign to develop a new generation vaccine for influenza
12 November 2007

Download

Eden Biodesign appoints Roger Lias as president Eden Biodesign, USA
05 November 2007

Download

Eden Biodesign and Borean Pharma ApS sign deal to develop novel therapeutic candidate for the treatment of cancer
10 September 2007

Download

Eden Biodesign selected by Cancer Research uk to develop and manufacture two therapeutic candidates for the treatment of advanced intra-abdominal and head and neck cancer
05 September 2007

Download

Eden Biodesign and the University of Manchester Intellectual Property Limited (UMIP) develop innovative treatment for cancer
06 August 2007

Download

Eden Biodesign and the University of Birmingham develop novel therapeutic candidate for the treatment of a range of autoimmune diseases
30 July 2007

Download

State-of-the-art manufacturing facility commences GMP production for a range of novel immunotherapeutics
21 May 2007

Download

Eden Biodesign and Immunobiology (ImmBio) develop next generation vaccine for the prevention of influenza
19 March 2007

Download

Eden Biodesign and IntelliHep are to develop a manufacturing process for heparin based therapeutics as potential treatments for diseases ranging from Alzheimer’s to inflammation
22 January 2007

Download

FILTER BY YEAR

REGISTER FOR INFORMATION

Register

To find out more information about Eden Biodesign, our services and our track record please contact us to request a copy of our brochure. If you would like one of our team to get in touch, please submit your details via our registration form.

STAY UP-TO-DATE

Find us on LinkedIn